Skip to main content

Table 1 Base case parameters

From: A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in Australia

Parameter

Value

Age

67.5 years [27]

Gender

40.5% [27]

Body mass index

31 kg/m2 [6]

History of VTE

7.7% [28]

Fraction THA

43.5% [8]

Fraction TKA

56.5% [9]

DVT incidence with LMWH

4.48% per 11.52 days [27]

PE incidence with LMWH

0.25% per 11.52 days [27]

Non-major bleed incidence with LMWH

9.9% per 12 days [28]

Major bleed incidence with LMWH

1.9% per 10 days [7]

  1. DVT deep vein thrombosis, LMWH low-molecular-weight heparin, PE pulmonary embolism, THA total hip arthroplasty, TKA total knee arthroplasty, VTE venous thromboembolism